Results 261 to 270 of about 72,976 (300)
Some of the next articles are maybe not open access.
Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release
European Journal of Pharmacology, 2000We have examined the selective neuropeptide Y Y(2) receptor antagonist, (S)-N(2)-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6h)-oxodibenz[b, e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl ]-N-[2-[1 ,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3-H-1,2, 4-triazol-4-yl]ethyl]-argininamid (BIIE0246) on neuropeptide release from rat hypothalamic slices in vitro.
P J, King +3 more
openaire +2 more sources
Neuropeptide Y receptor antagonists.
IDrugs : the investigational drugs journal, 2005A review of the patent literature for neuropeptide Y (NPY) antagonists is presented for the period of January 2000 to March 2001. This review focuses on antagonists of the Y(1) and Y(5) receptor subtypes, which have been of primary interest as anti-obesity agents.
openaire +1 more source
Neuropeptide Y (NPY) Y1 Receptor Antagonists
2001Neuropeptide Y(NPY), a 36-residue peptide amide isolated originally from porcine brain, exhibits a wide spectrum of central and peripheral activities mediated by at least six receptor subtypes denoted as Y1, Y2, Y3, Y4, Y5 and Y6 [1]. Investigations to date have implicated NPY in the pathophysiology of a number of diseases including feeding disorders ...
V. C. Dhawan +6 more
openaire +1 more source
Neuropeptide Y receptors in pig spleen
Acta Physiologica Scandinavica, 1987A, Härfstrand, J M, Lundberg, K, Fuxe
openaire +2 more sources
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues
Progress in Neurobiology, 1992Y, Dumont +4 more
openaire +2 more sources
Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Nature Reviews Drug Discovery, 2012Guy Griebel, Florian Holsboer
exaly
TRPV1 Pain Receptors Regulate Longevity and Metabolism by Neuropeptide Signaling
Cell, 2014Mark O Huising +2 more
exaly

